Enovis Stock
Enovis Corporation
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Damien McDonald
- Employees
- 7,802
- Market cap
- $1.1 B
- IPO
- 08/05/2008
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts,…
Enovis stock: price history
1D
+1.2%
1W
+10.7%
1M
+5.0%
6M
-25.6%
YTD
-26.5%
1Y
-37.2%
2Y
-52.0%
5Y
-77.5%
10Y
-61.3%
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~21% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 13/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Ask the agents about Enovis
Analyst assessment of Enovis
PRICE TARGET LOW
US$27.00
CONSENSUS
US$36.33
MEDIAN
US$35.00
PRICE TARGET HIGH
US$45.00
0
STRONG BUY
12
BUY
3
HOLD
0
SELL
0
STRONG SELL
15
TOTAL · Buy
As of: 12/10/2026
Enovis stock metrics
P/E
-1.01
P/B
0.76
EV/EBITDA
-3.47
RETURN ON EQUITY
-0.1%
NET MARGIN
-0.2%
DEBT/EQUITY
0.93
DIVIDEND YIELD
0.0%
AS OF
03/07/2026
Free float & liquidity
FREE FLOAT
97.5%
FLOAT SHARES
56,238,143
AVG. DAILY VOLUME (30D)
1,809,230
Insider transactions (SEC)
Ortiz Christine
Engert Oliver
McDonald Damien
Engert Oliver
Engert Oliver
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Enovis stock
What does Enovis do?
Enovis Corporation is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Damien McDonald, the company employs around 7,802 people.
The IPO was on 08/05/2008; the stock trades on NYSE under the ticker ENOV.
What do analysts say about Enovis stock?
15 analysts rate the stock, the consensus is Buy (as of 12/10/2026).
The average price target is US$36.33, ranging from US$27.00 to US$45.00, with a median of US$35.00.
This is an external assessment, not a statement by Market Jury.
When does Enovis report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 21% stronger than usual.
Does Enovis pay a dividend?
No, Enovis currently does not pay a dividend.
Which stocks are comparable to Enovis?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Enovis stock analyzed?
Clicking "Analyze stock" lets five strategies assess Enovis against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.